Sulfacetamide (Topical) - Uses, Dosage, Side effects, Contraindications

Sulfacetamide is a sulfonamide antibiotic that is used alone or combined with other medicines for the treatment of cutaneous and ocular conditions.

Sulfacetamide Uses:

  • Acne (Klaron lotion, topical suspension):

    • Treatment of acne vulgaris.
  • Bacterial infections (cream, wash, Ovace Plus lotion and foam):

    • Treatment of bacterial infections of the skin.
  • Scaling dermatoses (cream, shampoo, wash, Ovace Plus lotion and foam):

    • Treatment of scaling dermatoses (seborrheic dermatitis and seborrhea sicca [dandruff]).

It is also used in combination with prednisolone as eye ointment (Blephamide) and suspension for ocular inflammatory conditions.

Sulfacetamide Dose in Adults

Topical Sulfacetamide Dose in the treatment of Acne:

  • Klaron lotion, topical suspension:

    • Apply a thin film to affected area twice per day.

Topical Sulfacetamide Dose in the treatment of bacterial infections: 

  • Cream, Ovace Plus lotion:

    • do Apply to affected areas twice per day for 8 to 10 days.
  • Foam:

    • Apply to affected areas 1 to 3 times per day
  • Wash:

    • Apply to affected areas 1 to 2 times daily for 8 to 10 days.

Topical Sulfacetamide use in patients with Scaling dermatoses: 

  • Cream, Ovace Plus lotion:

    • Apply to affected areas twice daily for 8 to 10 days.
    • Dosing interval may be lengthened as eruption subsides.
    • Applications once or twice weekly, or every other week may be used for prevention.
    • If treatment needs to be reinitiated, start therapy as a twice-daily regimen.
  • Foam:

    • Apply to affected areas 1 to 3 times per day
  • Shampoo:

    • Wash hair at least twice weekly.
  • Wash:

    • Ovace Plus Wash Liquid, Ovace Plus Wash cleansing gel, Ovace wash:

      • Wash affected areas twice with a 10- to 20-second interval between washings;
      • repeat twice daily for 8 to 10 days.
      • Dosing interval may be lengthened as eruption subsides.
      • Applications once or twice weekly, or every other week may be used for prevention.
      • If treatment needs to be reinitiated, start therapy as a twice-daily regimen.
    • SEB-Prev:

      • Wash affected areas twice daily for 8 to 10 days.
      • Dosing interval may be lengthened as eruption subsides.
      • Applications once or twice weekly, or every other week may be used for prevention.
      • If treatment needs to be reinitiated, start therapy as a twice-daily regimen.

Sulfacetamide Dose in Childrens

Sulfacetamide Dose in the treatment of Acne:

  • Children ≥12 years and Adolescents:

    • Topical: Lotion 10%:

      • Apply a thin film to the affected area twice per day

Sulfacetamide use in the treatment of Seborrheic dermatitis, including seborrhea sicca:

Children ≥12 years and Adolescents: Topical:

  • Cream, Lotion 9.8%:

    • Apply to affected areas twice daily for 8 to 10 days.
    • Dosing interval may be lengthened as eruption subsides.
    • Applications once or twice weekly, or every other week may be used for prevention.
    • If treatment needs to be reinitiated, start therapy as a twice-daily regimen.
  • Foam:

    • Apply to affected areas 1 to 3 times per  day
  • Gel, Wash:

    • Wash affected area twice with a 10- to 20-second interval between washings;
    • repeat application twice per day for 8 to 10 days.
    • Dosing interval may be lengthened as eruption subsides.
    • Applications once or twice weekly, or every other week may be used for prevention.
    • If treatment needs to be reinitiated, start therapy as a twice-daily regimen.
  • Shampoo:

    • Wash hair at least twice weekly

Sulfacetamide Dose in the treatment of Secondary Cutaneous Bacterial infections:

  • Children ≥12 years and Adolescents: Topical:

    • Cream, Lotion 9.8%:

      • Apply to affected areas twice per day for 8 to 10 days
    • Foam:

      • Apply to affected areas 1 to 3 times per  day
    • Gel:

      • Wash affected area once a day for 8 to 10 days
    • Wash:

      • Wash affected area once or twice a day for 8 to 10 days

Pregnancy Risk Factor C

  • Studies on animal reproduction have not been done.
  • It is unknown how much sulfacetamide is available in the body after topical application.
  • Systemic sulfonamides may cause kernicterus in the baby if they are taken during pregnancy.

Sulfacetamide use during breastfeeding:

  • Breast milk excretes small amounts of sulfonamides taken orally. It is not known whether sulfacetamide topically excreted in breastmilk.
  • Breast-feeding with systemic sulfonamides can cause kernicterus in newborns.

Sulfacetamide Dose in Kidney impairment:

Not mentioned in the manufacturer's labeling.

Sulfacetamide Dose in liver disease:

Not mentioned in the manufacturer's labeling.

Side effects of Sulfacetamide:

  • Dermatologic:

    • Burning Sensation Of Skin
    • Erythema
    • Pruritus
    • Stevens-Johnson Syndrome
    • Stinging Of The Skin
    • Toxic Epidermal Necrolysis
  • Hematologic & Oncologic:

    • Agranulocytosis
    • Aplastic Anemia
    • Hematologic Abnormality
  • Hepatic:

    • Fulminant Hepatic Necrosis
  • Hypersensitivity:

    • Hypersensitivity Reaction
  • Local:

    • Local Irritation
    • Localized Edema
  • Neuromuscular & Skeletal:

    • Systemic Lupus Erythematosus

Contraindications to Sulfacetamide:

  • Hypersensitivity known or suspected to sulfonamides, or any component of the formulation
  • Kidney disease (Ovace Plus wash, Ovace Plus lotion and Ovace Plus foam).

Notice:

  • Although the FDA approved product labeling has claimed that this medication is contraindicated/not indicated with other sulfonamide-containing drug groups, the scientific basis of this statement has been challenged.
  • See "Warnings/Precautions" for more detail.

Warnings and precautions

  • Autoimmune effects:

    • Sulfonamides have been linked to severe reactions such as drug-induced systemic Lupus Erythematosus.
  • Blood dyscrasias:

    • Sulfonamides have been linked to severe reactions such as agranulocytosis and acute hemolytic anemia.
  • Dermatologic reactions

    • Sulfonamides have been linked to severe reactions such as Stevens-Johnson Syndrome, toxic epidermal necrolysis and drug fever.
    • Additionally, contact dermatitis and reddening of the skin can occur.
  • Hepatic effects

    • Sulfonamides have been linked to severe reactions that include jaundice and fulminant liver necrosis.
  • Hypersensitivity reactions

    • Patients who have never had sulfonamide hypersensitivity before may experience skin rash or other reactions.
    • Stop using the medication immediately if you feel hypersensitive or rash.
  • Allergy to sulfonamide ("sulfa")

    • Cross-reactivity concerns have been a concern for all compounds with the sulfonamide structural (SO NH).
    • A deeper understanding of allergic mechanisms suggests that cross-reactivity between non-antibiotic and antibiotic sulfonamides is unlikely.
    • Particularly, anaphylaxis (anaphylaxis) is unlikely to occur when 2 2 antibiotic sulfonamides or antibiotics sulfonamides are combined.
    • Sulfasalazine is an antibiotic sulfonamide that has an arylamine structure. It may cross-react with antibiotic sulfonamides.
    • T-cell-mediated reactions, i.e. type IV reactions, eg. the maculopapular skin rash are less understood. It is difficult to exclude this possibility based on current knowledge.
    • Some clinicians prefer to avoid drug exposure in cases of severe reactions (Stevens Johnson syndrome/TEN).
  • Systemic effects

    • Application to infected, abraded or burnt skin can increase systemic absorption.

Sulfacetamide (topical): Drug Interaction

Risk Factor C (Monitor therapy)

BCG Vaccine (Immunization)

Antibiotics may reduce the BCG vaccine's therapeutic effect (Immunization).

Risk Factor D (Consider therapy modification)

Sodium Picosulfate

Antibiotics may reduce Sodium Picosulfate's therapeutic impact. Management: If a patient previously used or is currently using an antibiotic, think about utilising an alternative product for bowel cleansing prior to a colonoscopy.

Risk Factor X (Avoid combination)

BCG (Intravesical)

Antibiotics may lessen BCG's therapeutic effects (Intravesical).

Monitoring parameters:

  • Response to therapy,
  • signs of local irritation and/or sensitization, especially during long-term therapy.

How to administer Sulfacetamide?

  • Topical:

    • Avoid contact with eyes and mucous membranes.
  • Foam:

    • Clean affected skin thoroughly and pat dry prior to each application.
    • Shake well prior to use.
    • Dispense into palm of the hand. Massage into affected areas and wait 10 minutes; rinse thoroughly with water and pat dry.
  • Lotion and topical suspension:

    • Shake well prior to use.
  • Shampoo:

    • Apply to wet hair and massage vigorously into the scalp; thoroughly rinse hair.
  • Wash:

    • Apply to wet skin and massage into a full lather, rinse thoroughly with plain water, and pat dry.
    • If skin dryness occurs, rinse off early or use less frequently.
    • When used for scaling dermatitis, regular shampooing after use is not necessary;
    • however, hair should be shampooed at least once a week.

Mechanism of action of Sulfacetamide:

  • Interferes in bacterial growth through inhibition of bacterial folic acids synthesis by competitive antagonism with PABA

Absorption:

  • Significant absorption through the skin has been reported; percutaneous absorption about 4%.

Metabolism:

  • Sulfanilamide (major metabolite)

Half-life elimination:

  • 7 to 13 hours

Excretion:

  • Urine 0.08% to 0.33%

International Brands of Sulfacetamide:

  • Klaron
  • Ovace Plus
  • Ovace Plus Wash
  • Ovace Wash
  • Seb-Prev Wash
  • Sodium Sulfacetamide Wash

Sulfacetamide Brand Names in Pakistan:

No Brands Available in Pakistan.